Published April 10, 2020 / Public health
The Covid-19 pandemic and the risks to drug supply and quality
Foundation members co-sign an article on Covid-19 and fake medicines published in The Lancet. 55 members of the Medicines We Can Trust campaign, including two foundation members, co-signed the article "COVID-19 and the risks associated with the supply and quality of diagnostic tests, medicines and vaccines" published yesterday in The Lancet.
While research into COVID-19 continues, it remains essential that all approved medicines are safe and accessible to everyone in the world. 55 members of the Medicines We Can Trust campaign from 20 countries, including Sir David Richmond and Kim Doyle, Chief Executive and the Foundation's Director of programmes and Partnerships, have co-signed the article "COVID-19 and the risks to the supply and quality of diagnostic tests, medicines and vaccines" published yesterday in the Lancet.
Access the article by clicking here.
Read also
Public health
Falsified medicines in Africa: Foulo Basse, guest on the Unlocking Africa podcast
02/03/2026
Public health
Foulo Basse: "Without strong action, fake medicines will continue to kill silently"
14/07/2025
